Association of preeclampsia with podocyte turnover

Clinical Journal of the American Society of Nephrology

Volumn 9, Issue 8, 2014, Pages 1377-1385

  Penning, Marlies E ^a   Bloemenkamp, Kitty W M ^a   Van Zon, Tom Der ^a   Zandbergen, Malu ^a   Schutte, Joke M ^b   Bruijn, Jan A ^a   Bajema, Ingeborg M ^a   Baelde, Hans J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Obstetrics Leiden University Medical Center ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN; KI 67 ANTIGEN; BIOLOGICAL MARKER; CD44 PROTEIN, HUMAN;

ADULT; ARTICLE; ATROPHY; AUTOPSY; CELL ACTIVATION; CELL COUNT; CELL PROLIFERATION; CELL SWELLING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE REGISTRY; EDEMA; FEMALE; FIBROSING ALVEOLITIS; FIBROSIS; GLOMERULAR ENDOTHELIOSIS; GLOMERULAR LESION; GLOMERULITIS; GLOMERULOSCLEROSIS; GLOMERULUS; GLOMERULUS BASEMENT MEMBRANE; HISTOLOGY; HUMAN; HUMAN TISSUE; HYALINE DEGENERATION; HYPEREMIA; HYPERTENSION; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; ISCHEMIA; KIDNEY DISEASE; KIDNEY TUBULE NECROSIS; MESANGIUM CELL; MICROTHROMBUS; MORPHOMETRICS; PATHOGENESIS; PODOCYTE; PREECLAMPSIA; PREGNANCY; TURNOVER TIME; CASE CONTROL STUDY; CAUSE OF DEATH; CHEMISTRY; KIDNEY DISEASES; METABOLISM; MORTALITY; NETHERLANDS; PATHOLOGY; REGISTER;

ADULT; ANTIGENS, CD44; AUTOPSY; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CAUSE OF DEATH; CELL PROLIFERATION; FEMALE; HUMANS; KI-67 ANTIGEN; KIDNEY DISEASES; NETHERLANDS; PODOCYTES; PRE-ECLAMPSIA; PREGNANCY; REGISTRIES;

EID: 84908172739     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.12811213     Document Type: Article

References (33)

1. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R: Preeclampsia. Lancet 376: 631–644, 2010.
2. Karumanchi SA, Maynard SE, Stillman IE, Epstein FH, Sukhatme VP: Preeclampsia: A renal perspective. Kidney Int 67: 2101– 2113, 2005.
3. Lohlein M: Zur Pathogenese der Nierenkrankheiten; Nephritis und Nephrose mit besonderes Beru¨cksichtigung der Nephropathia gravidarum. Dtsch Med Wochenschr 44: 1187– 1189, 1918.
4. Vikse BE: Pre-eclampsia and the risk of kidney disease. Lancet 382: 104–106, 2013.
5. Garovic VD, Wagner SJ, Turner ST, Rosenthal DW, Watson WJ, Brost BC, Rose CH, Gavrilova L, Craigo P, Bailey KR, Achenbach J, Schiffer M, Grande JP: Urinary podocyte excretion as a marker for preeclampsia. Am J Obstet Gynecol 196: e1–e7, 2007.
6. Kelder TP, Penning ME, Uh HW, Cohen D, Bloemenkamp KW, Bruijn JA, Scherjon SA, Baelde HJ: Quantitative polymerase chain reaction-based analysis of podocyturia is a feasible diagnostic toolin preeclampsia. Hypertension 60: 1538–1544, 2012.
7. Aita K, Etoh M, Hamada H, Yokoyama C, Takahashi A, Suzuki T, Hara M, Nagata M: Acute and transient podocyte loss and proteinuria in preeclampsia. Nephron Clin Pract 112: c65–c70, 2009.
8. Garovic VD, Wagner SJ, Petrovic LM, Gray CE, Hall P, Sugimoto H, Kalluri R, Grande JP: Glomerular expression of nephrin and synaptopodin, but not podocin, is decreased in kidney sections from women with preeclampsia. Nephrol Dial Transplant 22: 1136–1143, 2007.
9. Zhao S, Gu X, Groome LJ, Wang Y: Decreased nephrin and GLEPP-1, but increased VEGF, Flt-1, and nitrotyrosine, expressions in kidney tissue sections from women with preeclampsia. Reprod Sci 16: 970–979, 2009.
10. Casparie M, Tiebosch AT, Burger G, Blauwgeers H, van de Pol A, van Krieken JH, Meijer GA: Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive. Cell Oncol 29: 19–24, 2007.
11. Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM: The classification and diagnosis of the hypertensive disorders of pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 20: 9–16, 2001.
12. Schutte JM, Steegers EA, Schuitemaker NW, Santema JG, de Boer K, Pel M, Vermeulen G, Visser W, van Roosmalen J; Netherlands Maternal Mortality Committee: Rise in maternal mortality in the Netherlands. BJOG 117: 399–406, 2010.
13. Mundlos S, Pelletier J, Darveau A, Bachmann M, Winterpacht A, Zabel B: Nuclear localization of the protein encoded by the Wilms’ tumor gene WT1 in embryonic and adult tissues. Development 119: 1329–1341, 1993.
14. Scholzen T, Gerdes J: The Ki-67 protein: Fromthe known and the unknown. J Cell Physiol 182: 311–322, 2000.
15. Smeets B, Uhlig S, Fuss A, Mooren F, Wetzels JF, Floege J, Moeller MJ: Tracing the origin of glomerular extracapillary lesions from parietal epithelial cells. J Am Soc Nephrol 20: 2604–2615, 2009.
16. Strevens H, Wide-Swensson D, Hansen A, Horn T, Ingemarsson I, Larsen S, Willner J, Olsen S: Glomerular endotheliosis in normal pregnancy and pre-eclampsia. BJOG 110: 831–836, 2003.
17. Lemley KV, Bertram JF, Nicholas SB, White K: Estimation of glomerular podocyte number: A selection of validmethods. J Am Soc Nephrol 24: 1193–1202, 2013.
18. Fatima H, Moeller MJ, Smeets B, Yang HC, D’Agati VD, Alpers CE, Fogo AB: Parietal epithelial cell activation marker in early recurrence of FSGS in the transplant. Clin J Am Soc Nephrol 7: 1852–1858, 2012.
19. Weibel ER, GomezDM: A principle for counting tissue structures on random sections. J Appl Physiol 17: 343–348, 1962.
20. Appel D, Kershaw DB, Smeets B, Yuan G, Fuss A, Frye B, Elger M, Kriz W, Floege J, Moeller MJ: Recruitment of podocytes from glomerular parietal epithelial cells. J Am Soc Nephrol 20: 333– 343, 2009.
21. Craici IM, Wagner SJ, Bailey KR, Fitz-Gibbon PD, Wood-Wentz CM, Turner ST, Hayman SR, White WM, Brost BC, Rose CH, Grande JP, Garovic VD: Podocyturia predates proteinuria and clinical features of preeclampsia: Longitudinal prospective study. Hypertension 61: 1289–1296, 2013.
22. Peired A, Angelotti ML, Ronconi E, la Marca G, Mazzinghi B, Sisti A, Lombardi D, Giocaliere E, Della Bona M, Villanelli F, Parente E, Ballerini L, Sagrinati C, Wanner N, Huber TB, LiapisH, Lazzeri E, Lasagni L, Romagnani P: Proteinuria impairs podocyte regeneration by sequestering retinoic acid. J Am Soc Nephrol 24: 1756–1768, 2013.
23. Smeets B, Kuppe C, Sicking EM, Fuss A, Jirak P, van Kuppevelt TH, Endlich K, Wetzels JF, Gröne HJ, Floege J, Moeller MJ: Parietal epithelial cells participate in the formation of sclerotic lesions in focal segmental glomerulosclerosis. J AmSoc Nephrol 22: 1262– 1274, 2011.
24. Chipps TJ, Appukuttan B, Pan Y, Smith JR: CD44 isoforms in human retinal and choroidal endothelial cells. Graefes Arch Clin Exp Ophthalmol 251: 1245–1246, 2013.
25. Macconi D, Sangalli F, Bonomelli M, Conti S, Condorelli L, Gagliardini E, Remuzzi G, Remuzzi A: Podocyte repopulation contributes to regression of glomerular injury induced by ACE inhibition. Am J Pathol 174: 797–807, 2009.
26. Smeets B, Angelotti ML, Rizzo P, Dijkman H, Lazzeri E, Mooren F, Ballerini L, Parente E, Sagrinati C, Mazzinghi B, Ronconi E, Becherucci F, Benigni A, Steenbergen E, Lasagni L, Remuzzi G, Wetzels J, Romagnani P: Renal progenitor cells contribute to hyperplastic lesions of podocytopathies and crescentic glomerulonephritis. J Am Soc Nephrol 20: 2593–2603, 2009.
27. Vikse BE, Hallan S, Bostad L, Leivestad T, Iversen BM: Previous preeclampsia and risk for progression of biopsy-verified kidney disease to end-stage renal disease. Nephrol Dial Transplant 25: 3289–3296, 2010.
28. Vikse BE, Irgens LM, Leivestad T, Skjaerven R, Iversen BM: Preeclampsia and the risk of end-stage renal disease. N Engl J Med 359: 800–809, 2008.
29. Eremina V, Jefferson JA, Kowalewska J, Hochster H, Haas M, Weisstuch J, Richardson C, Kopp JB, Kabir MG, Backx PH, Gerber HP, Ferrara N, Barisoni L, Alpers CE, Quaggin SE: VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med 358: 1129–1136, 2008.
30. Sison K, Eremina V, Baelde H, Min W, Hirashima M, Fantus IG, Quaggin SE: Glomerular structure and function require paracrine, not autocrine, VEGF-VEGFR-2 signaling. J Am Soc Nephrol 21: 1691–1701, 2010.
31. Rana S, Karumanchi SA, Lindheimer MD: Angiogenic factors in diagnosis, management, and research in preeclampsia. Hypertension 63: 198–202, 2014.
32. Barisoni L, Schnaper HW, Kopp JB: Advances in the biology and genetics of the podocytopathies: Implications for diagnosis and therapy. Arch Pathol Lab Med 133: 201–216, 2009.
33. D’Agati VD: Podocyte injury in focal segmental glomerulosclerosis: Lessons from animal models (a play in five acts). Kidney Int 73: 399–406, 2008.